Want to track JANX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Janux Therapeutics, Inc. (JANX) Statistics
Valuation metrics
Market Cap 1.01B
Enterprise value 1.01B
Trailing P/E (ttm) -10.1
Forward P/E -
PEG ratio -1.59
Price/Sales (ttm) 42.44
Price/Book (mrq) 1.13
Enterprise Value/Revenue 42.16
Enterprise Value/EBITDA -10.05
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 649.05K
Average volume (90 days) 833.1K
Price summary
52-Week low 12.12
52-Week high 35.34
Beta -
50-Day moving average 17.3
200-Day moving average 15.87
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -4.27%
Operating margin -5.98%
Operational effectiveness
Return on assets -0.1%
Return on equity -0.11%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.38
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.63
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 15.43
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 16.35%
Book value per share (mrq) 14.74
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
